GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medipal Holdings Corp (TSE:7459) » Definitions » Cyclically Adjusted Revenue per Share

Medipal Holdings (TSE:7459) Cyclically Adjusted Revenue per Share : 円15,099.60 (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Medipal Holdings Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medipal Holdings's adjusted revenue per share for the three months ended in Dec. 2023 was 円4,439.308. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円15,099.60 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Medipal Holdings's average Cyclically Adjusted Revenue Growth Rate was 4.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medipal Holdings was 3.10% per year. The lowest was 2.20% per year. And the median was 2.40% per year.

As of today (2024-04-28), Medipal Holdings's current stock price is 円2467.50. Medipal Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円15,099.60. Medipal Holdings's Cyclically Adjusted PS Ratio of today is 0.16.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medipal Holdings was 0.21. The lowest was 0.11. And the median was 0.16.


Medipal Holdings Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Medipal Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipal Holdings Cyclically Adjusted Revenue per Share Chart

Medipal Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,943.30 13,309.00 13,493.60 13,888.70 14,576.50

Medipal Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,486.30 14,576.50 14,748.60 14,952.40 15,099.60

Competitive Comparison of Medipal Holdings's Cyclically Adjusted Revenue per Share

For the Medical Distribution subindustry, Medipal Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipal Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medipal Holdings's Cyclically Adjusted PS Ratio falls into.



Medipal Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medipal Holdings's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=4439.308/106.8000*106.8000
=4,439.308

Current CPI (Dec. 2023) = 106.8000.

Medipal Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 3,242.910 95.700 3,619.047
201406 3,061.084 98.000 3,335.957
201409 3,152.835 98.500 3,418.505
201412 3,381.672 97.900 3,689.097
201503 3,105.718 97.900 3,388.056
201506 3,278.571 98.400 3,558.449
201509 3,283.198 98.500 3,559.853
201512 3,560.395 98.100 3,876.149
201603 3,250.994 97.900 3,546.539
201606 3,407.757 98.100 3,709.974
201609 3,351.331 98.000 3,652.267
201612 3,529.339 98.400 3,830.624
201703 3,242.993 98.100 3,530.598
201706 3,446.400 98.500 3,736.807
201709 3,445.479 98.800 3,724.465
201712 3,691.039 99.400 3,965.825
201803 3,169.138 99.200 3,411.935
201806 3,370.361 99.200 3,628.574
201809 3,300.901 99.900 3,528.891
201812 3,558.545 99.700 3,811.962
201903 3,212.598 99.700 3,441.379
201906 3,431.711 99.800 3,672.412
201909 3,587.948 100.100 3,828.100
201912 3,708.633 100.500 3,941.114
202003 3,441.200 100.300 3,664.209
202006 3,546.808 99.900 3,791.783
202009 3,543.338 99.900 3,788.073
202012 3,791.695 99.300 4,078.077
202103 3,451.702 99.900 3,690.108
202106 3,687.277 99.500 3,957.801
202109 3,656.542 100.100 3,901.286
202112 3,862.950 100.100 4,121.509
202203 3,491.879 101.100 3,688.751
202206 3,744.592 101.800 3,928.511
202209 3,801.085 103.100 3,937.496
202212 4,200.865 104.100 4,309.821
202303 3,772.244 104.400 3,858.962
202306 4,146.828 105.200 4,209.898
202309 4,199.920 106.200 4,223.648
202312 4,439.308 106.800 4,439.308

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Medipal Holdings  (TSE:7459) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medipal Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2467.50/15099.6
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medipal Holdings was 0.21. The lowest was 0.11. And the median was 0.16.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medipal Holdings Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Medipal Holdings's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipal Holdings (TSE:7459) Business Description

Industry
Traded in Other Exchanges
Address
2-7-15, Yaesu, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.

Medipal Holdings (TSE:7459) Headlines

No Headlines